Linezolid-induced lactic acidosis and pancytopenia: one case report and literature review of 50 cases
10.16718/j.1009-7708.2017.04.004
- VernacularTitle:利奈唑胺致乳酸酸中毒及全血细胞减少1例报道及50例文献复习
- Author:
Yanyan ZHANG
;
Wan ZHU
;
Jingping ZHANG
;
Baiyi CHEN
- Keywords:
linezolid;
lactic acidosis;
pancytopenia;
adverse reaction
- From:
Chinese Journal of Infection and Chemotherapy
2017;17(4):365-370
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the adverse reaction profile of linezolid during clinical treatment,especially lactic acidosis and pancytopenia.Methods One case of linezolid-induced lactic acidosis and pancytopenia was described in a patient receiving long-term treatment in our hospital.Similar cases were searched and identified from literatures reports both in China and abroad from 2000 to 2015 for further review.The data were analyzed in terms of patient age,sex,underlying conditions,as well as onset time,clinical characteristics,and outcomes of the adverse reaction.Results A total of 50 similar cases (male/female ratio:1.78∶1) were analyzed,42.0％ of which were old patients (at least 65 years old).Liver and/or renal insufficiency was found in 20 cases (40.0％).The onset of lactic acidosis was at 5.5 weeks after initiation of linezolid on average,and the onset of pancytopenia was at 3.5 weeks after initiation of linezolid.Conclusions Linezolid-induced lactic acidosis or pancytopenia is more frequently found in the elderly patients with hepatic dysfunction and long-term treatment.
